FIBRODYSPLASIA OSSIFICANS PROGRESSIVA (FOP) TREATMENT MARKET ANALYSIS

Fibrodysplasia Ossificans Progressiva (FOP) Treatment Market, by Drug Class (Corticosteroids, NSAIDs, Bisphosphonates, and Others), by Route of Administration (Oral, Topical, and Parenteral), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022-2028

To Be Published : Nov 2024
Code : CMI3823
Formats :
Excel and PDF
Industry : Pharmaceutical

Market News

Moreover, acquisitions and mergers by market players to expand their product portfolios are likely to propel the market growth during the forecast period. For instance, in April 2019, Ipsen completed the acquisition of Clementia Pharmaceuticals. Through this acquisition Ipsen will be strengthening its portfolio of products for treating rare disorders such as fibrodysplasia ossificans progressiva.